A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer
A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer
Not yet recruiting · NCT07851103 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer | Advanced Solid Tumour | Not yet recruiting | Phase 1 | 2026-10-01 | NCT07851103 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University | Atlanta | United States | 262 |
| Florida Cancer Specialists-Sarasota-61670 | Sarasota | United States | 2 |
| Hospital Clinico De Valencia (INCLIVA) | Valencia | Spain | 6 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 200 |
| Institut Gustave Roussy | Villejuif | France | 54 |
| Japanese Foundation for Cancer Research | Tokyo, Koto-ku | Japan | 11 |
| Sarah Cannon Research Institute-Nashville-48456 | Nashville | United States | 3 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Thomas Jefferson University | Philadelphia | United States | 165 |
| Universitair Ziekenhuis Gent | Ghent | Belgium | 112 |